AI Generated Image
Weight Loss Drugs Linked to Extra Hair Loss Risk in Men
Newsweek • • health
Key Points:
- A new NYU Langone Health study found a genetic link suggesting men predisposed to male-pattern baldness may have a 7% increased risk of hair loss when using GLP-1 weight-loss drugs like Ozempic, Wegovy, and Zepbound.
- This research provides the first genetic evidence connecting GLP-1 receptor activity to androgenetic alopecia, beyond the previously assumed cause of rapid weight loss.
- The study analyzed genetic data from over 236,000 individuals, focusing on the GLP1R gene and its association with hair loss, and adjusted for factors like hypertension and testosterone levels.
- Experts caution the findings indicate a modest increased risk and do not prove that GLP-1 medications directly cause baldness, advising patients not to stop treatment without consulting a doctor.
- Researchers suggest future screening for hair loss risk before prescribing GLP-1 drugs and indicate that further studies are needed to clarify the mechanisms and potential effects on women.
